help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grino, M.
Right arrow Articles by Anglade, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grino, M.
Right arrow Articles by Anglade, G.

Endocrinology, Vol 135, 2549-2557, Copyright © 1994 by Endocrine Society


ARTICLES

Blockade of alpha 2-adrenoceptors stimulates basal and stress-induced adrenocorticotropin secretion in the developing rat through a central mechanism independent from corticotropin-releasing factor and arginine vasopressin

M Grino, O Paulmyer-Lacroix, M Faudon, M Renard and G Anglade
Laboratoire de Neuroendocrinologie Experimentale, INSERM U-297, Institut Federatif Jean Roche, Marseille, France.

In the neonatal rat, the response of the hypothalamo-pituitary-adrenal axis to stressful stimuli is markedly reduced during the first 2 weeks of life [stress-hyporesponsive period (SHRP)]. In this report, we studied the effect of idazoxan (an alpha 2-adrenergic antagonist) on plasma ACTH and corticosterone levels in 8-day-old rats. Indeed, it is known that in the adult rat, blockade of alpha 2-adrenoceptors increases ACTH secretion stimulated by CRF and arginine vasopressin (AVP) injection. Injection of 2.5 micrograms/g idazoxan induced a rapid (within 30 min) increase in basal plasma ACTH and corticosterone levels that lasted for 60 min. Injection of increasing doses of idazoxan led to a dose-dependent stimulation of ACTH and corticosterone levels. Administration of 2.5 micrograms/g idazoxan significantly increased the ACTH response to insulin-induced hypoglycemia, whereas it potentiated and accelerated the ACTH response to ether exposure stress. We next examined ACTH secretion from superfused anterior pituitary glands. Neither the alpha 2-adrenergic agonist clonidine nor idazoxan changed the basal ACTH secretory rate. Idazoxan had no effect on CRF- and AVP- stimulated ACTH secretion. This indicates that in vivo, idazoxan acts at a suprapituitary level. To investigate a possible effect of idazoxan on presynaptic alpha 2-adrenoceptors, we studied the effect of idazoxan on the concentrations of norepinephrine (NE) and L-DOPA in punches of locus coeruleus after dopa-decarboxylase blockade. Idazoxan injection induced a decrease in the NE content, without changing L-DOPA levels, indicating that idazoxan can act at the level of presynaptic alpha 2- adrenoceptors, inducing an increased release and/or degradation of NE without any effect on catecholamines synthesis. Finally, we investigated a possible involvement of CRF and AVP in mediating the effect of alpha 2-adrenoceptor blockade on ACTH secretion. Passive immunization against CRF or AVP did not change the ACTH response to idazoxan administration, whereas idazoxan pretreatment had simply an additive effect on CRF- and lysine vasopressin-stimulated ACTH secretion. In conclusion, our data demonstrate that during the SHRP, blockade of alpha 2-adrenoceptors induces an increase in both basal and stress-induced ACTH secretion. They suggest that a decreased catecholaminergic tone, consecutive to an increased occupation of alpha 2-adrenoceptors, acting through a central mechanism independent from CRF and AVP may be responsible for the SHRP in the developing rat.


This article has been cited by other articles:


Home page
EndocrinologyHome page
C. J. Rice, C. A. Sandman, M. R. Lenjavi, and T. Z. Baram
A Novel Mouse Model for Acute and Long-Lasting Consequences of Early Life Stress
Endocrinology, October 1, 2008; 149(10): 4892 - 4900.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Moriceau, D. A. Wilson, S. Levine, and R. M. Sullivan
Dual circuitry for odor-shock conditioning during infancy: corticosterone switches between fear and attraction via amygdala.
J. Neurosci., June 21, 2006; 26(25): 6737 - 6748.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Varma, J. He, B.-C. Shin, L. A. Weissfeld, and S. U. Devaskar
Postnatal intracerebroventricular exposure to leptin causes an altered adult female phenotype
Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1132 - E1141.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
D. P. Finn, A. L. Hudson, H. Kinoshita, T. L. Coventry, D. S. Jessop, D. J. Nutt, and M. S. Harbuz
Imidazoline2 (I2) Receptor- and {alpha}2- Adrenoceptor-Mediated Modulation of Hypothalamic-Pituitary-Adrenal Axis Activity in Control and Acute Restraint Stressed Rats
J Psychopharmacol, March 1, 2004; 18(1): 47 - 53.
[Abstract] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Varma, J. He, L. Weissfeld, and S. U. Devaskar
Postnatal intracerebroventricular exposure to neuropeptide Y causes weight loss in female adult rats
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1560 - R1566.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society